Clearstead Advisors
FLGT icon

Clearstead Advisors’s Fulgent Genetics FLGT Stock Holding History

Clearstead Advisors’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$452 Buy
22
+2
+10% +$34 ﹤0.01% 2952
2026
Q1 		$318 Hold
20
– – ﹤0.01% 2144
2025
Q4 		$526 Hold
20
– – ﹤0.01% 2305
2025
Q3 		$452 Hold
20
– – ﹤0.01% 2750
2025
Q2 		$398 Hold
20
– – ﹤0.01% 2512
2025
Q1 		$338 Hold
20
– – ﹤0.01% 2103
2024
Q4 		$370 Hold
20
– – ﹤0.01% 2003
2024
Q3 		$435 Hold
20
– – ﹤0.01% 1967
2024
Q2 		$393 Hold
20
– – ﹤0.01% 1950
2024
Q1 		$444 Hold
20
– – ﹤0.01% 1464
2023
Q4 		$579 Hold
20
– – ﹤0.01% 1450
2023
Q3 		$535 Hold
20
– – ﹤0.01% 1412
2023
Q2 		$741 Hold
20
– – ﹤0.01% 1276
2023
Q1 		$625 Sell
20
-48
-71% -$1.54K ﹤0.01% 1279
2022
Q4 		$2.02K Hold
68
– – ﹤0.01% 1090
2022
Q3 		$3K Hold
68
– – ﹤0.01% 1027
2022
Q2 		$4K Sell
68
-12
-15% -$659 ﹤0.01% 1027
2022
Q1 		$5K Hold
80
– – ﹤0.01% 1072
2021
Q4 		$8K Hold
80
– – ﹤0.01% 946
2021
Q3 		$7K Sell
80
-77
-49% -$7K ﹤0.01% 985
2021
Q2 		$14K Buy
157
+77
+96% +$6.15K ﹤0.01% 757
2021
Q1 		$8K Buy
80
+45
+129% +$4.64K ﹤0.01% 813
2020
Q4 		$2K Sell
35
-65
-65% -$2.72K ﹤0.01% 886
2020
Q3 		$4K Buy
+100
New +$3.13K ﹤0.01% 756

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Clearstead Advisors's FLGT Position: Q2 2026 in Review

Clearstead Advisors increased its Fulgent Genetics (FLGT) stake by 10% in Q2 2026, buying an estimated $34 and bringing the position to 22 shares worth $452. The position accounts for ﹤0.01% of the portfolio, ranked #2952.

Clearstead Advisors first reported a position in FLGT in Q3 2020 and has held it in 24 quarters since. The position peaked at $14K in Q2 2021. 141 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Clearstead Advisors held 22 shares of Fulgent Genetics worth $452 as of Q2 2026.
  • Clearstead Advisors bought 2 Fulgent Genetics shares in Q2 2026, an estimated $34.
  • Fulgent Genetics made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #2952 holding.
  • Clearstead Advisors first reported a position in Fulgent Genetics in Q3 2020 and has held it in 24 quarters since.
  • Clearstead Advisors's Fulgent Genetics position peaked at $14K in Q2 2021.
  • 141 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.